Protective effect of luk magsool in hyperlipidemia

Protective effect of luk magsool laccifera lacca in izdiaz shahmuddam hyperlipidemia - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076377

Enrollment

Registered

2024-11-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I709- Other and unspecified atherosclerosis

Interventions

Intervention1: LUK MAGSOOL: LUK MAGSOOL IN POWDER FORM DOSAGE 5 GM MORNING AND EVENING BEFORE MEAL FOR 2 MONTHS Control Intervention1: PLACEBO: Wheat husk in powder form filled in capsule one capsule

Eligibility

Inclusion criteria

Inclusion criteria: 1] Patient with impaired lipid level 2]patient with past history of hyperlipidemia

Exclusion criteria

Exclusion criteria: 1] Patient who are not giving informed consent 2]Patient with hereditary disease, liver disease,renal disease 3]Pregnancy and lactation 4]patient with splenic disease

Design outcomes

Primary

Measure	Time frame
To maintaina the cholesterol and triglycerides levelTimepoint: 0th day 60th day	—

Secondary

Measure	Time frame
To reduce BMITimepoint: 0TH DAY, 30th DAY, 60TH DAY	—

Countries

India

Contacts

Public ContactDr Fatima Furquan

Government Nizamia Tibbi College and general hospital

maqboolahmar@gmail.com9948679786

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026